On July 23, 2026, Dr Reddy's Laboratories Ltd RDY shares rose 3.7%, bringing the current price to $11.80. The stock has experienced notable volatility, with a 52-week range between $11.36 and $15.67, and year-to-date losses of 15.5%.
- GF Valueâ„¢ verdict: Current price is $11.80, suggesting a 13.2% upside to the GF Valueâ„¢ of $13.59.
- GF Scoreâ„¢ is 83/100, indicating a strong overall performance based on key financial metrics.
- Most notable signal: No insider transactions in the last 3 months suggest a neutral sentiment among insiders.
Is RDY Overvalued or Undervalued?
Dr Reddy's Laboratories Ltd RDY is currently trading at $11.80, which is 13.2% below its GF Valueâ„¢ of $13.59. This indicates that the stock is undervalued and presents a potential opportunity for investors looking for bargains in the pharmaceutical sector. The margin of safety afforded by this valuation suggests that there might be a cushion against potential downside risks. It is important to note that while the GF Valuation label indicates RDY is "Modestly Undervalued," investors should still exercise caution, as market conditions can affect stock performance.
GF Valueâ„¢ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.
How Does RDY's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | 26.8x | 23.0x |
| Forward P/E | 22.6x | - |
The current P/E (TTM) of 26.8x is 16% above its 5-year median P/E of 23.0x, indicating that RDY is trading above its historical valuation. This P/E analysis somewhat disagrees with the GF Valueâ„¢ verdict, suggesting that while the stock may be undervalued based on intrinsic metrics, it is currently priced higher relative to its historical earnings capacity.
What Does RDY's GF Scoreâ„¢ Tell Us?
| Metric | Rating |
|---|---|
| GF Scoreâ„¢ | 83/100 |
| Financial Strength | 8/10 |
| Profitability | 9/10 |
| Growth | 9/10 |
| Valuation | 10/10 |
| Momentum | 1/10 |
The GF Scoreâ„¢ of 83/100 showcases a strong overall performance, particularly in the areas of Profitability (9/10), Growth (9/10), and Valuation (10/10). However, the low Momentum score of 1/10 highlights a potential weakness, indicating that the stock has not performed well in the short term. Overall, the scores indicate that while RDY has solid fundamentals, its recent price action may raise concerns among investors.
What Are Insiders Doing with RDY Stock?
There have been no insider transactions for Dr Reddy's Laboratories Ltd RDY in the last three months. This lack of activity suggests a neutral sentiment among insiders, which may indicate that they do not see immediate opportunities for buying or selling at current price levels.
What This Means for Investors
Based on the GF Valueâ„¢ assessment, Dr Reddy's Laboratories Ltd RDY appears to be undervalued at the current price of $11.80. However, potential investors should consider the stock's recent performance and high P/E ratio relative to its historical average when making decisions.
For the complete analysis, visit the Dr Reddy's Laboratories Ltd RDY stock page. You can also explore the GF Valueâ„¢ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions
What is RDY's GF Scoreâ„¢?
RDY's GF Scoreâ„¢ is 83/100, indicating a strong overall performance based on key financial metrics.
Is RDY overvalued or undervalued?
RDY is currently undervalued with a GF Valueâ„¢ of $13.59 compared to its current price of $11.80.
What is RDY's P/E ratio?
RDY's P/E (TTM) is 26.8x, which is above its 5-year median P/E of 23.0x, indicating that the stock is trading at a premium relative to its historical valuation.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
